Related Experiment Video
Updated: May 9, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Patient characteristics and severity of human rhinovirus infections in children
Ina L Lauinger1, Jon M Bible, Eugene P Halligan
1Department of Infectious Diseases, King's College London School of Medicine, London, UK.
Insights
Human rhinovirus species C (HRV-C) is the most common cause of respiratory infections in children. HRV-C infections are linked to more severe disease in children under three years old.
Area of Science:
- Pediatric Infectious Diseases
- Virology
- Respiratory Medicine
Background:
- Human rhinoviruses (HRV) are increasingly linked to severe infections.
- Conflicting data exists regarding the prevalence and severity of different HRV species.
Purpose of the Study:
- To investigate the prevalence and clinical features of HRV-A, HRV-B, and HRV-C in children with respiratory tract infections.
- To determine if specific HRV species are associated with more severe disease in children.
Main Methods:
- Retrospective review of respiratory tract infection cases in children under 16.
- Detection of entero/rhinovirus RNA in respiratory samples.
- Analysis of patient characteristics and co-pathogens.
Main Results:
- Entero/rhinoviruses were the most common viral pathogens (21.5%).
- HRV-C was the most prevalent HRV species (59.3%), followed by HRV-A (35.9%) and HRV-B (4.8%).
- HRV-C mono-infection was associated with more severe disease in children under three years old.
Conclusions:
- HRV-C is the most prevalent HRV species and is associated with severe disease in young children.
- The clinical presentation of HRV infections is complex and influenced by co-pathogens and underlying conditions.
Background:
It is increasingly recognized that human rhinoviruses (HRV) can be associated with severe infections. However, conflicting results have been reported on the relative prevalence and severity of the three HRV species.
Objectives:
The relative prevalence and clinical characteristics of HRV-A, B and C, in children attending a South London teaching hospital were investigated retrospectively.
Study Design:
Children aged<16 years with episodes of respiratory tract infections and detectable entero/rhinovirus RNA in respiratory samples between November 2009 and December 2010 were investigated. Retrospective case review was performed and patients' characteristics recorded.
Results:
Entero/rhinoviruses were the commonest viral pathogens (498/2316; 21.5%). Amongst 204 infection episodes associated with entero/rhinovirus, 167 were typed HRV, HRV-C was the most prevalent (99/167, 59.3%) followed by HRV-A (60/167; 35.9%) and HRV-B (8/167, 4.8%). The severity spectrum of HRV-A and HRV-C infections were similar and affected all parts of the respiratory tract. Co-pathogens were observed in 54 (26.5%) episodes. Severity was increased in patients with non-viral co-pathogens and those with an underlying respiratory condition. Univariate and multiple regression analyses of potential prognostic variables including age, co-pathogens and underlying respiratory illnesses showed that mono-infection with HRV-C, as compared with other HRV species, was associated with more severe disease in young children<3 years.
Conclusions:
HRV-C was the most prevalent species and on its own was associated with severe disease in children<3 years. The association between infection with HRV species and clinical presentation is complex and affected by many confounding factors.
Related Concept Videos
Influenza
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Asthma I: Introduction
